10% Lidocaine spray for IUD insertion in nulliparous wome

Not Applicable

• Conditions: IUD insertion; intrautetine device; Lidocaine spray

• Registration Number: TCTR20180815004
• Lead Sponsor: Faculty of Medicine Siriraj Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-05-15
• Study Completion: 2019-06-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: Female
• Target Recruitment: 124

Inclusion Criteria

Woman who required for Copper T IUD insertion
Age 18-45 years
New IUD user
Body mass index 18.5 †30 kg/m2
Communicable with Thai language

Exclusion Criteria

Suspicion of pregnancy
Puerperal sepsis/Immediate post-septic abortion
Untreated abnormal uterine bleeding
Uterine anomaly/abnormal pathology distorting the uterine cavity
Current pelvic inflammatory disease
Untreated cervicitis/vaginitis
Wilson’s disease
Copper allergy
known hypersensitivity to local anaesthetics.
Analgesic or anxiolytic use within the last 24 h before the procedure

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain score immediately after removal of IUD insertion tube visual analog scale

Secondary Outcome Measures

Name	Time	Method
side effect (uterine perforation,irritation, dizziness) after completion of IUD insertion procedure Yes of No